From: Cost-effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model
Disease | Disutility value | Reference or assumption |
---|---|---|
Meningitis (inpatient)* | 0.023 | [22] |
Bacteremia (inpatient)* | 0.008 | [22] |
Pneumonia (inpatient)* | 0.008 | Assumed to be the same as inpatient bacteremia |
Pneumonia (outpatient)* | 0.006 | [22] |
AOM (outpatient)* | 0.005 | [23] |
AOM hospitalized myringotomy* | 0.005 | Assumed to be the same as for AOM outpatient |